135 related articles for article (PubMed ID: 8720617)
1. Interferon-alpha and IDDM: comment.
Foulis AK
Diabetologia; 1996 Jan; 39(1):127. PubMed ID: 8720617
[No Abstract] [Full Text] [Related]
2. Antibodies to glutamic acid decarboxylase induced by interferon-alpha therapy for chronic viral hepatitis.
Imagawa A; Itoh N; Hanafusa T; Waguri M; Kuwajima M; Matsuzawa Y
Diabetologia; 1996 Jan; 39(1):126. PubMed ID: 8720616
[No Abstract] [Full Text] [Related]
3. Focal expression of interleukin-2 does not break unresponsiveness to "self" (viral) antigen expressed in beta cells but enhances development of autoimmune disease (diabetes) after initiation of an anti-self immune response.
von Herrath MG; Allison J; Miller JF; Oldstone MB
J Clin Invest; 1995 Feb; 95(2):477-85. PubMed ID: 7860729
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of IDDM during interferon therapy for chronic viral hepatitis.
Waguri M; Hanafusa T; Itoh N; Imagawa A; Miyagawa J; Kawata S; Kono N; Kuwajima M; Matsuzawa Y
Diabetes Res Clin Pract; 1994 Feb; 23(1):33-6. PubMed ID: 8013261
[TBL] [Abstract][Full Text] [Related]
5. Induction of type I diabetes by interferon-alpha in transgenic mice.
Stewart TA; Hultgren B; Huang X; Pitts-Meek S; Hully J; MacLachlan NJ
Science; 1993 Jun; 260(5116):1942-6. PubMed ID: 8100367
[TBL] [Abstract][Full Text] [Related]
6. Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.
Chong MM; Chen Y; Darwiche R; Dudek NL; Irawaty W; Santamaria P; Allison J; Kay TW; Thomas HE
J Immunol; 2004 May; 172(9):5714-21. PubMed ID: 15100317
[TBL] [Abstract][Full Text] [Related]
7. Altered MHC class I expression: a role for transplantation and IDDM autoimmunity.
Faustman DL
Diabetes Metab Rev; 1995 Apr; 11(1):1-19. PubMed ID: 7600904
[No Abstract] [Full Text] [Related]
8. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain.
Lund T; O'Reilly L; Hutchings P; Kanagawa O; Simpson E; Gravely R; Chandler P; Dyson J; Picard JK; Edwards A
Nature; 1990 Jun; 345(6277):727-9. PubMed ID: 2163026
[TBL] [Abstract][Full Text] [Related]
9. The pathology of the endocrine pancreas in type 1 (insulin-dependent) diabetes mellitus.
Foulis AK
APMIS; 1996 Mar; 104(3):161-7. PubMed ID: 8611188
[TBL] [Abstract][Full Text] [Related]
10. Caution is required with interferon alpha as a potential treatment for type I diabetes.
Beales PE; Pozzilli P
Diabetologia; 1999 Mar; 42(3):385. PubMed ID: 10096798
[No Abstract] [Full Text] [Related]
11. Low incidence of autoimmune type I diabetes in BB rats fed a hydrolysed casein-based diet associated with early inhibition of non-macrophage-dependent hyperexpression of MHC class I molecules on beta cells.
Li XB; Scott FW; Park YH; Yoon JW
Diabetologia; 1995 Oct; 38(10):1138-47. PubMed ID: 8690165
[TBL] [Abstract][Full Text] [Related]
12. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
von Herrath M; Holz A
J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
[TBL] [Abstract][Full Text] [Related]
13. [Autoantibodies against islet cell antigens and type 1 diabetes after treatment with interferon-alpha].
Schories M; Peters T; Rasenack J; Reincke M
Dtsch Med Wochenschr; 2004 May; 129(20):1120-4. PubMed ID: 15143453
[TBL] [Abstract][Full Text] [Related]
14. Tolerance and diabetes in transgenic mice over-expressing class I histocompatibility molecules in pancreatic beta cells.
Miller JF; Allison J; Morahan G
J Autoimmun; 1990 Apr; 3 Suppl 1():87-90. PubMed ID: 2187464
[TBL] [Abstract][Full Text] [Related]
15. Male-specific beta-cell dysfunction and diabetes resulting from increased expression of a syngeneic MHC class I protein in the pancreata of transgenic mice.
Martin L; Keller GA; Liggitt D; Oakley H; Pitts-Meek SL; Siegel MW; Terrell T; Stewart TA
New Biol; 1990 Dec; 2(12):1101-10. PubMed ID: 1965148
[TBL] [Abstract][Full Text] [Related]
16. [Augmentation of the immune response to islet cell antigens with development of diabetes mellitus caused by interferon-alpha therapy in chronic hepatitis C].
Seifarth C; Benninger J; Böhm BO; Wiest-Ladenburger U; Hahn EG; Hensen J
Z Gastroenterol; 1999 Mar; 37(3):235-9. PubMed ID: 10234796
[TBL] [Abstract][Full Text] [Related]
17. Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice.
von Herrath MG; Dyrberg T; Oldstone MB
J Clin Invest; 1996 Sep; 98(6):1324-31. PubMed ID: 8823297
[TBL] [Abstract][Full Text] [Related]
18. [Molecular mechanisms of beta-cell destruction in type 1 diabetes].
Mandrup-Poulsen TR
Ugeskr Laeger; 2001 Aug; 163(32):4176-9. PubMed ID: 11510233
[No Abstract] [Full Text] [Related]
19. Interferon-alpha and interferon-gamma differentially affect pancreatic beta-cell phenotype and function.
Baldeón ME; Chun T; Gaskins HR
Am J Physiol; 1998 Jul; 275(1):C25-32. PubMed ID: 9688831
[TBL] [Abstract][Full Text] [Related]
20. Prevention of diabetes in non-obese diabetic I-Ak transgenic mice.
Slattery RM; Kjer-Nielsen L; Allison J; Charlton B; Mandel TE; Miller JF
Nature; 1990 Jun; 345(6277):724-6. PubMed ID: 1972779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
